RxDoctor Payments DataLook up a doctor →

Amy Allen

Family · Knoxville, TNNPI 1780725168

Payments from drug & device makers

$20,668in general payments, 2019–2025

Across 933 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Johnson & Johnson$1K
  • Novartis$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Incyte Corporation$896
  • Amgen$845
  • plus $14K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)60$1,379
Johnson & Johnson39$1,151
Novartis55$1,067
E.r. Squibb & Sons, L.L.C.49$1,044
Incyte Corporation33$896
Amgen39$845
Genentech USA, Inc.42$823
Sanofi31$784
Seagen Inc.34$767
Pfizer38$760
Merck33$726
Astellas Pharma US Inc32$717
Gilead(2 entities)29$705
Bristol Myers Squibb42$685
Regeneron Healthcare Solutions, Inc.23$597
Eisai Inc.30$591
AbbVie24$554
Daiichi Sankyo Inc.25$518
GSK23$492
Bayer21$411
Takeda Pharmaceuticals U.S.A., Inc.18$405
Lilly USA, LLC19$388
Karyopharm Therapeutics Inc.13$368
Pharmacyclics LLC, An Abbvie Company16$273
Exelixis Inc.9$221
AVEO Pharmaceuticals, Inc.6$205
Deciphera Pharmaceuticals Inc.9$204
Jazz Pharmaceuticals Inc.5$171
Morphosys, US Inc.6$156
Beigene USA, Inc.7$154
Genmab U.S., Inc.7$147
Boehringer Ingelheim7$146
Tersera Therapeutics LLC7$138
Ipsen Biopharmaceuticals, Inc6$134
Array Biopharma Inc6$123
Sobi, Inc6$122
EMD Serono, Inc.6$119
Rigel Pharmaceuticals, Inc.6$112
Mirati Therapeutics, Inc.4$107
Beone Medicines USA, Inc.4$90
Myriad Genetic Laboratories, Inc.5$89
Pharmacosmos Therapeutics Inc.4$84
Novocure Inc.5$83
Sanofi-aventis U.S. LLC1$83
Stemline Therapeutics Inc.3$74
Taiho Oncology, Inc.4$73
Geron Corporation3$72
Blueprint Medicines Corporation3$70
Servier Pharmaceuticals LLC3$69
Myovant Sciences Inc.4$68
G1 Therapeutics, Inc.3$68
ADC Therapeutics America, Inc.3$64
Epizyme, Inc.3$46
Janssen Scientific Affairs, LLC1$35
Caris MPI, Inc.1$33
Puma Biotechnology, Inc.2$33
Immunogen, Inc.1$29
Secura Bio, Inc.2$27
Syndax Pharmaceuticals, Inc.1$27
TG Therapeutics, Inc.1$25

How this compares

$20,668 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Medicare billing

Part B allowed, 2024
$16,410
Medicare patients
43
Services billed
255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Knoxville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →